Rafael Sánchez

ORCID: 0000-0002-5105-4207
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Dermatology and Skin Diseases
  • Nutrition and Health in Aging
  • Libraries, Manuscripts, and Books
  • Urticaria and Related Conditions
  • Central Venous Catheters and Hemodialysis
  • Mechanical Behavior of Composites
  • COVID-19 Clinical Research Studies
  • Advanced Breast Cancer Therapies
  • Body Composition Measurement Techniques
  • HER2/EGFR in Cancer Research
  • Cancer Treatment and Pharmacology
  • Clinical Nutrition and Gastroenterology
  • Muscle and Compartmental Disorders
  • COVID-19 and healthcare impacts
  • Advanced Surface Polishing Techniques
  • Psoriasis: Treatment and Pathogenesis
  • Renal function and acid-base balance
  • Ethics and bioethics in healthcare
  • Asthma and respiratory diseases
  • Nursing care and research
  • Pancreatitis Pathology and Treatment
  • Potassium and Related Disorders
  • Chronic Kidney Disease and Diabetes
  • Long-Term Effects of COVID-19

Hospital Universitario La Paz
2016-2025

Hospital General Universitario de Alicante Doctor Balmis
1991-2024

Acerinox (Spain)
1998-2024

Sociedad Española de Nefrología
2023-2024

Instituto Nacional de Rehabilitación
2024

Institut Català d'Oncologia
2015-2023

GEICAM – Spanish Breast Cancer Group
2022-2023

Hospital Universitari Joan XXIII de Tarragona
2008-2022

Hospital de Sant Joan Despí Moisès Broggi
2018-2022

Hospital Universitario Infanta Leonor
2022

1009 Background: Trastuzumab deruxtecan (T-DXd) is approved for adult patients (pts) with HER2+ advanced/metastatic breast cancer (mBC) who received a prior anti-HER2–based regimen. DESTINY-Breast07 Phase 1b/2 multicenter, open-label, modular study exploring the safety, tolerability, and antitumor activity of T-DXd alone or in combination other anticancer agents (NCT04538742). These results are from an interim analysis dose-expansion phase assessing ± pertuzumab (P) as first-line (1L)...

10.1200/jco.2024.42.16_suppl.1009 article EN Journal of Clinical Oncology 2024-05-29

Background. Depending on the cytokine microenvironment, macrophages (Mφ) can adopt a proinflammatory (M1) or profibrotic (M2) phenotype characterized by expression of cell surface proteins such as CD206 and CD163 soluble factors CC chemokine ligand 18 (CCL18). A key role for Mφ in fibrosis has been observed diverse organ settings. We studied population human model peritoneal dialysis which continuous stress due to fluids recurrent peritonitis represent risk membrane dysfunction reflected...

10.1093/ndt/gfq771 article EN Nephrology Dialysis Transplantation 2011-02-15

Background. Peritoneal membrane deterioration during peritoneal dialysis (PD) is associated with epithelial-to-mesenchymal transition (EMT) of mesothelial cells (MC), which believed to be mainly due glucose degradation products (GDPs) present in PD solutions. Here we investigate the impact GDPs solutions on EMT MC vitro and ex vivo.

10.1093/ndt/gfq357 article EN Nephrology Dialysis Transplantation 2010-06-22

Chronic kidney disease-associated pruritus (CKD-aP), a persistent itching sensation, is prevalent among hemodialysis patients. This study aims to understand its prevalence, possible association with selected solutes, and impact on quality of life (QoL) in Involving 434 patients Spain, this observational employed survey based validated assessment tools, alongside demographic, clinical, biochemical data collection. The used statistical analyses examine the correlation between CKD-aP various...

10.1038/s41598-024-83833-2 article EN cc-by-nc-nd Scientific Reports 2025-02-20

Patients with Stage 5 chronic kidney disease who are on hemodialysis (HD) remain in a inflammatory state, characterized by the accumulation of uremic toxins that induce endothelial damage and cardiovascular (CVD). Our aim was to examine microvesicles (MVs), monocyte subpopulations, angiopoietins (Ang) identify prognostic markers HD patients or without diabetes mellitus (DM). A total 160 prevalent from 10 centers across Spain were obtained Biobank Nephrology Renal Network (Madrid, Spain): 80...

10.1152/ajprenal.00013.2016 article EN AJP Renal Physiology 2017-01-11
Sol Carriazo Manuel Ignacio Aparicio-Madre Fernando Tornero-Molina Milagros Fernández‐Lucas Vicente Paraíso-Cuevas and 88 more Emilio González‐Parra Francisco del Río-Gallegos María Marqués Roberto Alcázar Arroyo Judith Martins Rafael Sánchez Beatriz Gil-Casares Eduardo Gutiérrez-Martínez María Pilar Martínez-Rubio Alberto Ortíz Maria Ángeles Goicoechea Diezhandino María Luisa Rodríguez Ferrero Soraya Abad Estébanez Milagros Fernández Lucas Nuria Rodríguez Mendiola Martha Díaz Domínguez Sandra Elías Triviño Víctor Burguera Vion Carlos Jiménez Martín Auxiliadora Bajo Rubio Rafael Selgas Gutiérrez Á. Alonso Melgar Laura Espinosa Román José Pórtoles Beatriz Sobrino Rosario Llópez Carratalá José Antonio Herrero Calvo Isabel Flores Ana Sánchez‐Fructuoso Paula Jara Caro-Espada Elena Gutiérrez Solís Catalina Martín-Cleary Ana Ramos Verde Jesús Hernández Pérez Guillermina Barril Cuadrado Martín Giorgi González Antonio Fernández Perpén Cristina Bernis Carro Patricia Martínez‐Miguel María Fuensanta Moreno Barrio Hanane Bouarich María Pérez Fernández Enrique Gruss Vergara Gema Fernández‐Juárez Eduardo Gallego Valcarce Ana Tato Ribera Juan Carlos Herrero Berrón María Teresa Naya Nieto Alfonso Cubas Alcaraz Fernando Tornero Molina Beatriz Gil-Casares Casanova Elda Besada Estévez Vicente Paraíso Cuevas Jesús Benito García Alicia García Pérez Valeria Sáiz Prestel Patricia de Sequera Ortiz Rocío Echarri Carrillo María Covadonga Hevia Ojanguren María del Carmen Jiménez Herrero Simona Alexandru Saul Enrique Pampa Saíco Rosa Sánchez Hernández Rocío Zamora González-Mariño Laura Rodríguez-Osorio Jiménez Beatríz Durá Gúrpide Elisa Ruiz Cícero Cristina Albarracín Sierra Ramón Delgado Lillo M Yagüe D Jorge Valencia Alonso Raquel Gota Ángel Aurelio Sanz Guajardo Carlos Jiménez Martín Jesús Hernández Pérez Karina Ruth Furaz Czerpak Ángel Agustín Méndez Abreu Ana Botella Lorenzo Javier Naranjo Sanz María Teresa Villaverde Ares Sandra Castellano Gasch María del Pilar Martínez Rubio Patricia Nora Estrada Villanueva José Ramón Berlanga Alvarado Ana María Blanco Santos Carmen Gámez Matías Pablo Mateos Hernández Marta Sanz Sainz

Kidney replacement therapy (KRT) confers the highest risk of death from coronavirus disease 2019 (COVID-19). However, most data refer to early pandemic waves. Whole-year analysis compared with prior secular trends are scarce.We present 2020 REMER Madrid KRT registry, corresponding Spanish Region hardest hit by COVID-19.In 2020, incidence decreased 12% versus 2019, while prevalence 1.75% for first time since records began and number kidney transplants (KTs) 16%. Mortality on was 10.2% (34%...

10.1093/ndt/gfac234 article EN Nephrology Dialysis Transplantation 2022-08-04

The guarantee of surface integrity has become a primary objective for researchers when analysing the reliability machined aircraft aluminium alloy structural parts in high-speed machining. This work studies effect cutting speed on face milled 7050-T7451 workpieces. First, workpieces were under dry conditions using three speeds (200, 800, 1400 m/min) at constant feed (0.20 mm/tooth) and depth cut (1 mm). An indexable milling cutter with diameter 50 mm five uncoated inserts was used tests....

10.1016/j.procir.2018.05.034 article EN Procedia CIRP 2018-01-01
Nuria Aresté Fosalba J. Emilio Sánchez-Álvarez Mario Prieto‐Velasco Pablo Molina Vicent Esteve-Simó and 94 more Raquel Ojeda Juan Manuel Buades Marián Goicoechea Rafael Sánchez Guillermo Alcalde Bezhold Rosa Elena Pérez-Morales Ana Blanco Santos Roser Peiró-Jordan María Dolores Arenas Ana Cristina Andrade Miguel Seras Mozas Paola Villabón José Luis Pérez Canga Natalia Andrés Torre Maria Jesús Moyano Franco Pablo Bouza Piñeiro María Fernanda Arrojo Alonso Willy Bernales Guerra Agustín Carreño Nerea Gómez Maria Slon Ramón González Joaquín Manrique I. Albo Castaño J.Tapia Sanz Edgardo Chacón J Solar Asuncion Ferrer‐Nadal Susana García Melendreras Jordi Soler Gregorio Romero Maribel Troya Fredzzia Graterol Francisco Henriquez Ortega Fernando Henríquez Isabel María Martín Báez Ana Isabel Martínez Puerto Elena Araceli Jiménez Vívora Silvia Benito García María Jesús Lloret Vanesa Martín Chica Victoria Mascarós Ferrer Catalina Beatriz Ulloa Clavijo Julia Mejido Moro María del Carmen Merino Bueno Belén Vizcaíno Belén Morales Franco Elba Díaz Ana María Oltra Benavent Sofía Ortego Sofía Palomo Aparicio Sara Piqueras Sánchez José Pórtoles Félix Valentín González Andrea Zapata Balcázar José Luis Rodriguez García F. González Sastre Manuel Fernández Martín Karina Furaz José C. De La Flor María Ortíz Sánchez Alfredo Cordón Nardeth Benavides Alicia González Mireilla Zeballos Ángel Méndez Mariano Acuña Daniel Galán Elena Guerrero Ana Botella Javier Naranjo Felipe Zalamea Paula Manso Delfina Yetman Damián Carneiro Mara Lisbet Cabana Carcasi Laura Beato Marina Burgos da Silva Marc Handel María Luz Sánchez Margarita Delgado Cerón María Melissa Vasquez Marta San Juan Luis Nieto Ramiro Cazar Jesús Hernández José Guerrero Carrillo María Isabel Martínez Araceli E. Rossignoli Maria Soledad Pizarro-Sánchez Lola Piña Emilio González‐Parra Mónica Pereira María Concepción Ferreira Feijoo

10.1093/ckj/sfac246 article EN cc-by-nc Clinical Kidney Journal 2023-03-23

Background. Patients starting peritoneal dialysis (PD) with active cardiovascular disease (CVD) show higher protein and albumin levels in effluent. Peripheral arterial (PAD) is increasingly recognized as an entity particularly associated mortality. Methods. To explore whether daily clearance (PrC) on PD a risk marker, we have formulated the hypothesis that PAD, expression of highest CVD grade, specifically related to amount PrC. Results. The average 24-h effluent losses (PPL) was 6.88 ± 3.31...

10.1093/ndt/gfn595 article EN Nephrology Dialysis Transplantation 2008-10-08

<b><i>Background/Aims:</i></b> A recent alert from Spanish health authorities warned of a higher incidence reported hypersensitivity reactions to hemodialysis membranes with polysulfone, in the 2017 review acute dialyzers found only published reports 21<sup>st</sup> century on polysulfone and its derivatives. The aim is assess/evaluate current characteristics patients. <b><i>Methods:</i></b> retrospective multicentre study 9...

10.1159/000493662 article EN cc-by-nc-nd Kidney & Blood Pressure Research 2018-01-01

Uremic pruritus (UP) is one of the most uncomfortable symptoms for patients in dialysis. UP has a great impact on dialysis patients' quality life and prevalence between those (28–70%). Physiopathology unknown usually unnoticed nephrologists (in more than 65% centers underdiagnosed). This lack awareness drives to unsuccessful treatment this symptom. Moreover, fact that studies have been carried out small populations difficulty assessing complicates correct therapeutical approach. For reason,...

10.1016/j.nefroe.2022.02.004 article ES cc-by-nc-nd Nefrología (English Edition) 2022-01-01

The treatment of cirrhotic patients with ascites and end-stage renal disease is complex, due mainly to decreased effective arterial volume hemodynamic instability. Peritoneal dialysis as a continuous therapy represents an alternative hemodialysis-related intolerance. We report on our experience that others treated by peritoneal dialysis. Hemodynamic tolerance was excellent in all solute water transport increased above the normal range almost cases. Morbidity mortality were related...

10.1177/089686080802800203 article EN Peritoneal Dialysis International 2008-03-01

Our aim was to evaluate the prognostic value of 2 measurements serum adiponectin levels for all-cause mortality and cardiovascular (CV) in uremic patients.We analyzed 184 patients (19-86 years) undergoing peritoneal dialysis (n = 86) or hemodialysis 98). All had (at baseline after 1 year). Relationships between were studied by means survival analysis Cox regression analysis.During a median follow-up time 31.2 months, 67 (36.4%) died, 26 (14.1%) as result CV disease. Mean with 1-year values...

10.1159/000221147 article EN American Journal of Nephrology 2009-01-01

Advanced oxidation protein products (AOPPs) are considered as markers and even mediators of the proinflammatory effect oxidative stress in uremia. We hypothesized that an increase associated with peritoneal dialysis (PD), estimated by variation plasma AOPPs over time, might be cardiovascular (CV) risk overall prognosis. In 48 PD patients, blood samples were collected on two occasions: first one six months after starting therapy second one, year after. The level was significantly CV...

10.1155/2015/219569 article EN cc-by Oxidative Medicine and Cellular Longevity 2015-01-01

El prurito asociado a la enfermedad renal crónica (Pa-ERC) es una de las comorbilidades más comunes e incapacitantes en los pacientes con ERC avanzada. Además, está un mayor riesgo mortalidad, peor calidad vida, aparición trastornos del sueño, alteraciones salud mental y uso recursos sanitarios. La presentación clínica Pa-ERC muy heterogénea, lo que dificulta su diagnóstico tratamiento. Actualmente, no existen guías nivel nacional sobre el manejo Pa-ERC. objetivo este documento proporcionar...

10.1016/j.nefro.2023.04.006 article ES cc-by-nc-nd Nefrología 2023-04-20

Several cases of patients with anaphylactic or systemic hypersensitivity reactions to polysulfone (PS) hemodialysis (HD) membranes and tolerance cellulose triacetate (CTA) have recently been reported. To investigate the mechanisms involved in PS hypersensitivity, basophil, T cell, complement activation were analyzed acute-phase samples from two PS-based membranes. Basophil cell activation, as well higher serum tryptase levels detected compared basal levels. Complement (C3 C4) decreased...

10.1111/aor.12954 article EN Artificial Organs 2017-07-19

Abstract Background: Detectable troponin below the 99th percentile may reflect an underlying cardiac abnormality which might entail prognostic consequences. This study aimed to investigate prognosis of patients admitted emergency department (ED) with detectable reference limit who did not present acute coronary syndrome (ACS). Methods: We analysed clinical data all consecutive ED during years 2012 and 2013 in whom was requested by attending clinician (cTnI Ultra Siemens, Advia Centaur)....

10.1515/cclm-2017-1140 article EN Clinical Chemistry and Laboratory Medicine (CCLM) 2018-05-01
Coming Soon ...